Pituitary metastasis: is there still a place for neurosurgical treatment? V. GilardC. AlexandruO. Langlois Topic Review 29 October 2015 Pages: 219 - 224
Preclinical studies of 5-fluoro-2′-deoxycytidine and tetrahydrouridine in pediatric brain tumors Marie MorfouaceBirgit NimmervollMartine F. Roussel Laboratory Investigation Open access 30 October 2015 Pages: 225 - 234
Temozolomide reverses doxorubicin resistance by inhibiting P-glycoprotein in malignant glioma cells Rong ZhangRyuta SaitoTeiji Tominaga Laboratory Investigation 04 November 2015 Pages: 235 - 242
Tumor location, but not H3.3K27M, significantly influences the blood–brain-barrier permeability in a genetic mouse model of pediatric high-grade glioma Ergys SubashiFrancisco J. CorderoG. Allan Johnson Laboratory Investigation 28 October 2015 Pages: 243 - 251
AshwaMAX and Withaferin A inhibits gliomas in cellular and murine orthotopic models Edwin ChangChristoph PohlingSanjiv S. Gambhir Laboratory Investigation 09 December 2015 Pages: 253 - 264
Association between RAD 51 rs1801320 and susceptibility to glioblastoma S. FranceschiS. TomeiA. G. Naccarato Laboratory Investigation 28 October 2015 Pages: 265 - 270
Therapeutic potential of cyclooxygenase-3 inhibitors in the management of glioblastoma Ersoy OksuzFatmahan AtalarZeliha Yazici Laboratory Investigation 27 October 2015 Pages: 271 - 278
Advanced MRI may complement histological diagnosis of lower grade gliomas and help in predicting survival Valeria CuccariniA. ErbettaM. Eoli Clinical Study 14 October 2015 Pages: 279 - 288
Leukoencephalopathy in long term brain metastases survivors treated with radiosurgery Or Cohen-InbarPatrick MelmerJason P. Sheehan Clinical Study 14 October 2015 Pages: 289 - 298
Impact of cognitive function on communication in patients with primary or secondary brain tumours Diana N. NaehrigEng-Siew KohHaryana M. Dhillon Clinical Study 26 October 2015 Pages: 299 - 307
A randomized phase I/II study of ABT-888 in combination with temozolomide in recurrent temozolomide resistant glioblastoma: an NRG oncology RTOG group study H. Ian RobinsPeixin ZhangMinesh Mehta Clinical Study 27 October 2015 Pages: 309 - 316
Tryptophan PET predicts spatial and temporal patterns of post-treatment glioblastoma progression detected by contrast-enhanced MRI Edit BosnyákDavid O. KamsonCsaba Juhász Clinical Study 29 October 2015 Pages: 317 - 325
CogState computerized memory tests in patients with brain metastases: secondary endpoint results of NRG Oncology RTOG 0933 Chip CaineSnehal DeshmukhLisa Kachnic Clinical Study 28 October 2015 Pages: 327 - 336
Impact of provider level, training and gender on the utilization of palliative care and hospice in neuro-oncology: a North-American survey Tobias WalbertMichael GlantzVinay K. Puduvalli Clinical Study 30 October 2015 Pages: 337 - 345
Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide Johan A. F. KoekkoekLinda DirvenMartin J. B. Taphoorn Clinical Study Open access 07 November 2015 Pages: 347 - 354
Development of brain metastases in patients with metastatic melanoma while receiving ipilimumab C. FrenardL. PeuvrelB. Dreno Clinical Study 28 October 2015 Pages: 355 - 360
Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma Julia TichySabrina SpechtmeyerChristian Foerch Clinical Study 30 October 2015 Pages: 361 - 369
Pediatric brain tumors in a low/middle income country: does it differ from that in developed world? Sameera EzzatMohamed KamalMohamed Saad Zaghloul Clinical Study 29 October 2015 Pages: 371 - 376
